0001209191-18-014717.txt : 20180228 0001209191-18-014717.hdr.sgml : 20180228 20180228193222 ACCESSION NUMBER: 0001209191-18-014717 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180226 FILED AS OF DATE: 20180228 DATE AS OF CHANGE: 20180228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knickerbocker Aron Marc CENTRAL INDEX KEY: 0001578766 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36070 FILM NUMBER: 18653920 MAIL ADDRESS: STREET 1: C/O FIVE PRIME THERAPEUTICS, INC. STREET 2: TWO CORPORATE DRIVE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: FIVE PRIME THERAPEUTICS INC CENTRAL INDEX KEY: 0001175505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260038620 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-365-5600 MAIL ADDRESS: STREET 1: 111 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-26 0 0001175505 FIVE PRIME THERAPEUTICS INC FPRX 0001578766 Knickerbocker Aron Marc 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 1 1 0 0 President & CEO Common Stock 2018-02-26 4 A 0 13845 0.00 A 191367 D Common Stock 15083 I By the Aron M. Knickerbocker Revocable Trust Employee Stock Option (right to buy) 18.69 2018-02-26 4 A 0 83070 0.00 A 2028-02-25 Common Stock 83070 83070 D Represents shares of restricted stock, which will vest according to the following schedule: one-third (1/3) of the restricted stock will vest on each of February 26, 2019, 2020 and 2021, provided the reporting person provides services to Five Prime Therapeutics, Inc. (the "Company") through each such date. Includes 1 share acquired on November 15, 2017 pursuant to the Company's 2013 Employee Stock Purchase Plan. The shares underlying the option vest at a rate of one forty-eighth (1/48th) per month following February 26, 2018, provided the reporting person provides services the Company through each such date. /s/ Francis Sarena, Attorney-in-Fact 2018-02-28